baber/WOPTO huggingface dataset:
Patent WO-2020106482-A1 (WO)
Title: Programming and controlling compute units in an integrated circuit
Inventor: SOE SOREN
IPC: G06F9/54
Filed: 2019-11-11
Abstract: An integrated circuit (150) (IC) can include a command queue (162) having a plurality of slots corresponding to commands from a host processor (105) for execution by a plurality of compute units (180) of the IC (150) and a command request register (164) having a plurality of locations corresponding to the plurality of slots in the command queue (162). The command request register (164) is configured to generate an interrupt indicating a new command (208) stored within the command queue (162). The IC (150) can include a controller (168) configured to, in response to the interrupt from the command request register (164), determine a selected compute unit (180-1) that is idle from the plurality of compute units (180) to execute the new command (208). The IC (150) can also include a compute unit direct memory access circuit configured to provide the new command [208] to the available compute unit.
Patent WO-2021107955-A1 (WO)
Title: Apport d'entrées à des dispositifs informatiques
Inventor: KE HSIANG-TA
IPC: G06F3/01
Filed: 2019-11-27
Abstract: L'invention porte sur des techniques permettant d'apporter des entrées à des dispositifs informatiques. Selon un exemple, un dispositif informatique peut afficher une interface d'entrée en fonction du regard d'un utilisateur. L'interface d'entrée peut comprendre une pluralité de touches, dont chacune peut être sélectionnée par l'utilisateur pour apporter une entrée au dispositif informatique. En fonction du regard de l'utilisateur en direction d'une touche, le dispositif informatique peut déterminer que l'utilisateur a sélectionné la touche et effectuer une action correspondant à la touche sélectionnée.
Patent WO-2020123246-A1 (WO)
Inventor: KUMAR VIKRAM
IPC: A61K45/06
Filed: 2019-12-05
Abstract: The invention provides methods of treating a condition in a subject by providing multiple therapeutic agents that target different pathways but achieve the same phenotypic response. The invention also provides methods of treating a condition in a subject by providing multiple therapeutic agents that target the same pathway. The methods are useful for treating conditions, such as cancer, using agents to which subjects may develop resistance.
Patent WO-2020142300-A1 (WO)
Inventor: CENTURION MATTHEW E
IPC: G06F8/41
Filed: 2019-12-23
Abstract: L'invention concerne un procédé qui peut consister : à rechercher un code compilé pour un nom variable d'une ressource, le nom variable contenant une chaîne prédéfinie ; à identifier un nom variable dans un manifeste de ressources de la bibliothèque qui correspond au nom variable qui contient la chaîne prédéfinie ; sur la base de l'identification, à importer la ressource vers un emplacement associé au code compilé.
Patent WO-2020146563-A1 (WO)
Inventor: LONG ADRIENNE
IPC: H01J49/04
Filed: 2020-01-09
Abstract: The present invention relates, in part, to methods of treating a cancer in a subject comprising administering to the subject a therapeutically effective amount of an agent that modulates one or more biomarkers, such as inhibits one or more biomarkers listed in Table 1 and/or increases one or more biomarkers listed in Table 4, in combination with an immunotherapy.
Patent WO-2020146898-A1 (WO)
Inventor: DING LEI
IPC: G01S15/06
Filed: 2020-01-13
Abstract: Ultrasonic ranging systems and methods that use coding to distinguish emitted bursts from multiple transducers temporally stagger (1404) the bursts (1402) emitted from the transducers. The stagger delay (1404) between bursts from different transducers in a sensing frame can be randomized between different sensing frames to prevent blind zones. The stagger delay can be relatively small (e.g., between 3 ms and 10 ms) as compared to delays required between bursts in a single-tone ranging system (which would need to be more on the order of between 30 ms and 40 ms, depending on the maximum detecting range of the ranging system). The coding of bursts can be selected to utilize the entire bandwidth of the bursting transducer so as to preserve short-range sensitivity over transducer ringing. Schemes in which some transducers in a system only listen for bursts from other transducers, but do not themselves burst within a sensing frame, are also described.
Patent WO-2020163818-A1 (WO)
Inventor: ZHANG PEIMING
IPC: G01N33/00
Filed: 2020-02-07
Abstract: This invention is related to electronic identification and sensing of biomolecules using enzymes incorporated into nanostructures constructed with conductive peptides and/or peptide complexes.
Patent WO-2020176814-A1 (WO)
Inventor: NIIMI HIROAKI
IPC: H01L21/02
Filed: 2020-02-27
Abstract: Low-resistivity dual silicide contacts for aggressively scaled semiconductor devices. A semiconductor device includes a first raised feature in a n-type channel field effect transistor (NFET) region on a substrate, a first n-type doped epitaxial semiconductor material wrapped around the first raised feature, a first metal silicide contact layer wrapped around the first n-type doped epitaxial semiconductor material, a second raised feature in p-type channel field effect transistor (PFET) region on the substrate, a second p-type epitaxial semiconductor material wrapped around the second raised feature, and a second metal silicide contact layer wrapped around the second p-type doped epitaxial semiconductor material. The first metal silicide contact layer can include a titanium silicide and the second metal silicide contact layer can include a ruthenium silicide.
Patent WO-2020181114-A1 (WO)
Title: Dynamic covalently linked hydrogels as stabilization network platforms
Inventor: MARCO-DUFORT BRUNO
IPC: C08G65/329
Filed: 2020-03-05
Abstract: The present invention provides dynamically covalent polymeric hydrogel systems for encapsulating and stabilizing bioactive therapeutic agents (e.g., proteins, cells, viruses, and vaccines) from environmental stressors, obviating standard refrigeration requirements, and decreasing transportation and storage costs of temperature-sensitive biomolecules. Described herein are dynamic polymeric hydrogel compositions comprising a therapeutic agent and a combination of phenylboronic acid- and l,2-diol- modified multi-arm polyethylene glycol (PEG) polymer backbones. Methods of encapsulating and stabilizing bioactive therapeutic agents within the dynamic polymeric hydrogel compositions are also provided. Also described are methods for releasing stabilized therapeutic agents from hydrogel encapsulation. The covalently adaptable hydrogel release systems allow for discretionary administration of temperature-sensitive therapeutic agents, as well as the parenteral administration of highly concentrated amounts of therapeutic agents.
Patent WO-2020209983-A1 (WO)
Inventor: MENGUY MICHEL TEVA
IPC: G02B6/44
Filed: 2020-03-16
Abstract: An optical connection module includes a housing, a first connector panel coupled to the housing, a first splicing tray coupled to the housing, and a first group of intermediate optical fibers extending from the first connector panel. The module is selectively expandable to further include one or more expansion connector panels, one or more expansion splicing trays, and a second group of intermediate optical fibers, thereby offering an increased number of optical connections provided by the module. A method of expanding the number of optical connections provided by an optical connection module through the selective addition of one or more expansion connector panels and one or more expansion splicing trays is also disclosed.
Patent WO-2020191356-A1 (WO)
Title: Anti-fructose therapy for colorectal and small intestine cancers
Inventor: GONCALVES MARCUS
IPC: A61P35/04
Filed: 2020-03-20
Abstract: As described herein ingestion of high amounts of sugar, especially fructose, can increase the growth of intestinal tumors. Such cancer growth can be inhibited or prevented by limiting the amounts of sugar and amino acids ingested, by inhibiting ketohexokinase (KHK), fructose transport (via GLUT5), fatty acid synthesis (via FASN), phosphoinositide 3-kinases (PI3K), or by limiting amounts of sugar and amino acids ingested while also receiving KHK inhibitors, GLUT5 inhibitors, FASN inhibitors, PI3K inhibitors, or a combination of such inhibitors.
Patent WO-2020198334-A1 (WO)
Title: Direct print chassis and platform for contact hearing system
Inventor: BISHOP MARK
IPC: H02J7/02
Filed: 2020-03-25
Abstract: A contact hearing device includes a chassis, sulcus platform and umbo platform wherein the chassis is formed as a single continuous material, the sulcus platform is formed as a single continuous material, and the umbo platform is formed as a single continuous material. The chassis may include a receiver mount, a motor mount pocket and a central frame. The sulcus platform includes one or more registration features adapted to mate with at least a portion of the chassis, the umbo platform includes a drive post landing pad, the drive post landing pad including at least one alignment feature.
Patent WO-2020226896-A1 (WO)
Title: Non-blocking switch matrix for multi-beam antenna
Inventor: ELIASSI RAVASH
IPC: H03K17/76
Filed: 2020-04-22
Abstract: A crossbar switch is disclosed having a first port, a second port, a third port, and a fourth port, the crossbar switch comprising: a first switching element coupled between the first port and the third port; a second switching element coupled between the first port and the fourth port; a third switching element coupled between the second port and the third port; and a fourth switching element coupled between the second port and the fourth port, wherein the first switching element, the second switching element, the third switching element, and the fourth switching element are configured to couple only one of the first port and the second port to the third port, at any given time.
Patent WO-2020223530-A1 (WO)
Title: Promédicaments à base de gemcitabine
Inventor: SHINDE RAJESH
IPC: C07H19/10
Filed: 2020-04-30
Abstract: La présente invention concerne des composés de promédicament de dérivé de gemcitabine phosphorylés, des compositions pharmaceutiques comprenant lesdits composés, et des procédés d'utilisation desdits composés pour le traitement du cancer.
Patent WO-2020223613-A1 (WO)
Inventor: JOSEPH VINAY
IPC: H04L5/00
Filed: 2020-05-01
Abstract: Various aspects of the present disclosure generally relate to wireless communication. In some aspects, a user equipment (UE) may determine that handling of a protocol data unit (PDU) by the UE is preempted. The UE may transmit an indication that the preempted PDU is preempted. The indication may be generated by a physical layer of the UE, or by a MAC layer of the UE. The UE may receive information for a transmission of the preempted PDU. Numerous other aspects are provided.
Patent WO-2020227600-A1 (WO)
Inventor: GALIPEAU JACQUES
IPC: C12N5/078
Filed: 2020-05-08
Abstract: A washed platelet extract with increased platelet growth factor concentration and decreased total protein relative to platelet rich plasma, and methods of making and using such an extract for the treatment of disease and injuries recited herein, are provided.
Patent WO-2020251790-A1 (WO)
Inventor: CHAN MAGGIE
IPC: G06F9/455
Filed: 2020-06-01
Abstract: An electronic device includes a processor that executes a guest operating system; a memory having a guest portion that is reserved for storing data and information to be accessed by the guest operating system; and an input-output memory management unit (IOMMU). The IOMMU writes, in the guest portion, information into guest buffers and/or logs used for communicating information from the IOMMU to the guest operating system. The IOMMU also reads, from the guest portion, information in guest buffers and/or logs used for communicating information from the guest operating system to the IOMMU.
Patent WO-2020252400-A1 (WO)
Title: Methods and system for artificial intelligence powered user interface
Inventor: VANGE MARK
IPC: A63F13/67
Filed: 2020-06-12
Abstract: Systems and methods for an artificial intelligence powered user interface according to various aspects of the present technology include a game engine that is powered by an artificial intelligence system that is able to receive minimal platform specific discrete user inputs and infer optimal in-game action. The game engine may be trained to generate a set of known, expected, or predicted behaviors for both non-player characters and actual players. The game engine may then present one or more events to players and then infer a player response based upon a received user input. The game engine may also be configured to measure success of each inference based on a comparison of a player's response to a set of predetermined goals.
Patent WO-2020264013-A1 (WO)
Title: Real-time augmented-reality costuming
Inventor: COWBURN PIERS
IPC: H04W4/02
Filed: 2020-06-24
Abstract: An augmented-reality costume system for performing operations that include: causing display of a presentation of image data at a first client device; detecting a second client device in proximity with the first client device based on location data from the second client device, the second client device associated with a user profile that comprises user profile data; identifying a display of an object at a position within the presentation of the image data based on the location data from the client device, the display of the object comprising image features; accessing the user profile data from the user profile associated with the second client device, the user profile data comprising AR content; and presenting the AR content within the presentation of the image data at the first client device based on at least the position of the object within the presentation of the image data.
Patent WO-2021016411-A1 (WO)
Inventor: BRGOCH JAKOAH
IPC: H01L33/50
Filed: 2020-07-23
Abstract: L'invention concerne des phosphores de formule : (A1-xEux)(Ba1-ySry)B9O15, les variables étant telles que définies dans le descriptif. L'invention concerne également des procédés de production des phosphores. Selon certains aspects, la présente invention concerne des dispositifs électroluminescents comprenant ces phosphores.
Patent WO-2021026377-A1 (WO)
Title: Composés contenant du lactame pour le traitement de la douleur
Inventor: PENNINGTON LEWIS D
IPC: A61P25/04
Filed: 2020-08-06
Abstract: L'invention concerne des composés qui sont utiles dans le traitement de la douleur chez un sujet. L'invention concerne également une composition pharmaceutique comprenant des composés ou des sels pharmaceutiquement acceptables de ceux-ci, et un support pharmaceutiquement acceptable et des procédés de traitement de la douleur chez un sujet en ayant besoin.
Patent WO-2021016626-A1 (WO)
Title: Disposable endoscopy cannula with integrated grasper
Inventor: OUYANG BRUCE
IPC: A61B17/30
Filed: 2020-08-12
Abstract: An endoscopic system includes an integrated grasper device passing through a device lumen in the cannula. The grasper device has distal end forming two jaw portions that are biased to remain in an open position if unconstrained. The grasper has arch shaped portions that push against the inner surface of the device lumen when the grasper is retracted. To close the jaws of the grasper the grasper is retracted proximally until the arch shaped portions engage the opening of the device lumen. Further retraction causes the grasper jaws to close through engagement with the device lumen inner surface. The endoscopy system can include a single-use, removable cannula having a camera module on its distal tip. A re-usable portion can include the hand piece and display screen.
Patent WO-2021045946-A1 (WO)
Title: Acoustic reporting for dynamic implants
Inventor: BAE YOUNGSAM
IPC: A61B17/00
Filed: 2020-08-26
Abstract: This disclosure concerns devices and methods for measuring an amount of adjustment of an expandable implant using ultrasound. The implant may include an ultrasound counter including a vibration element tuned for ultrasonic vibration, the vibration element may be configured to produce an ultrasound vibration upon an adjustment of the expandable implant.
Patent WO-2021067164-A1 (WO)
Title: Compositions cosmétiques capillaires contenant des composés cationiques, du panthénol et des huiles
Inventor: ASLAN SEYMA
IPC: A61K8/39
Filed: 2020-09-28
Abstract: La présente invention concerne des compositions cosmétiques capillaires qui comprennent un copolymère de vinylpyrrolidone cationique, un agent épaississant cationique comprenant au moins une unité dérivée d'acide acrylique ou méthacrylique, un tensioactif cationique, comprenant un tensioactif cationisable; un alcool gras, présent en une quantité supérieure ou égale à environ 3 % en poids; du panthénol, une silicone à fonction amino, une huile végétale ou de plante, en une quantité inférieure ou égale à environ 4,5 % en poids ; et de l'eau. L'invention concerne également des procédés d'utilisation de telles compositions cosmétiques capillaires.
Patent WO-2021067601-A1 (WO)
Inventor: MANICKA YATHEENDHAR
IPC: G08B1/08
Filed: 2020-10-01
Abstract: Application and associated methods relate to facilitating verification of authenticity of a product instance. Such verification of authenticity is facilitated by a verification transceiver configured to be affixed to a product instance. The verification transceiver includes an engagement fixture configured to affix the verification transceiver to a product instance. The verification transceiver includes a receiver configured to receive a query signal from a proximate mobile device. The verification transceiver includes a transmitter configured to transmit a current encoded signal indicative of the product instance in response to receiving the query signal. The verification transceiver also includes a verification-code sequencer configured to advance the current encoded signal to a next encoded signal in a sequence of encoded signals, each of the sequence indicative of the product instance, current encoded signal advanced to be transmitted in response to a next received query signal.
Patent WO-2022075981-A1 (WO)
Inventor: MAKAU FREDRICK
IPC: B01D69/10
Filed: 2020-10-07
Abstract: La présente invention concerne des membranes à effet de mèche de fluide, des procédés de fabrication de membranes à effet de mèche de fluide, et des membranes de dosage d'écoulement. Dans un exemple, une membrane à effet de mèche de fluide peut comprendre un substrat et une couche de revêtement poreuse sur le substrat. La couche de revêtement poreuse peut comprendre des particules de silice liées ensemble par un liant polymère. Les particules de silice peuvent avoir une taille moyenne de particule de plus de 1 pm à 50 pm. La couche de revêtement poreuse peut également comprendre un agent d'activation de surface activant des surfaces des particules de silice. L'agent d'activation de surface peut comprendre un hydrate de chlorure d'aluminium, un oxyde métallique trivalent, un oxyde métallique tétravalent, ou une combinaison de ceux-ci.
Patent WO-2021076377-A1 (WO)
Title: Networking device configuration value persistence
Inventor: NARSIAN ANISH
IPC: G06F11/14
Filed: 2020-10-08
Abstract: Configuration value persistence management (CVPM) tools and techniques provide faster persistence of networking device configuration values than classic approaches. CVPM consolidates configuration dump events based on certain dump conditions. Configuration value changes are journaled, and running configuration values are dumped to a data store only when the dump conditions are satisfied, instead of dumping all of the running configuration values whenever any of them is changed. Both the persistence of configurations and the restoration of persisted configurations are described. Configuration dump conditions may utilize device availability indicators, device load calculations, configuration change load calculations, dump age, or journal size, for example, or combinations thereof, with various thresholds. Thresholds may be hard, soft, or probabilistic. A wide variety of kinds of configuration values for many different kinds of networking devices may be efficiently and safely persisted and restored using CVPM in various computing environments.
Patent WO-2021080929-A1 (WO)
Inventor: KEYLOR MITCHELL
IPC: C07D239/78
Filed: 2020-10-20
Abstract: La présente invention concerne certains dérivés de N-hétéroaryl indazole substitués de formule (I) : et des sels pharmaceutiquement acceptables de ceux-ci, J, R3, et R4 étant tels que définis dans l'invention. Lesdits dérivés et sels sont de puissants inhibiteurs de la kinase LRRK2 et peuvent être utiles dans le traitement ou la prévention de maladies dans lesquelles la kinase LRRK2 est impliquée, telles que la maladie de Parkinson et d'autres maladies et troubles décrits ici. L'invention concerne également des compositions pharmaceutiques comportant lesdits composés et l'utilisation de ces composés et compositions dans la prévention ou le traitement de maladies, telles que la maladie de Parkinson, dans lesquelles la kinase LRRK2 est impliquée.
Patent WO-2021081378-A1 (WO)
Title: Gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
Inventor: CHARTIER-COURTAUD CECILE
IPC: A61K39/00
Filed: 2020-10-23
Abstract: The present invention provides improved and/or shortened methods for expanding TILs and producing therapeutic populations of TILs, including novel methods for expanding TIL populations in a closed system that lead to improved efficacy, improved phenotype, and increased metabolic health of the TILs in a shorter time period, while allowing for reduced microbial contamination as well as decreased costs. The methods may comprise gene-editing at least a portion of the TILs to enhance their therapeutic efficacy. Such TILs find use in therapeutic treatment regimens.
Patent WO-2021091714-A1 (WO)
Inventor: TROIANI MATTEO
IPC: H04B7/06
Filed: 2020-10-26
Abstract: Various embodiments of signal shaping systems are disclosed. In some embodiments, a signal shaping system comprises an input configured to receive an input signal. The input signal is transmitted as an optic signal. The signal shaping system comprises a first delay module to generate a first delay signal with a first delay compared to the input signal and a second delay module to generate a second delay signal with a second delay compared to the first delay signal. An inverter is configured to invert the first delay signal to generate an inverted first delay signal. A signal addition operation module is configured to add the inverted first delay signal and the second delay signal together and create a first pulse with a duration of the second delay and a second pulse with a duration of the second delay. An amplifier is configured to cut off the first pulse and amplify the second pulse. A bias loop module is configured to keep the amplifier near a cutoff region.
Patent WO-2021086904-A1 (WO)
Inventor: JANUSZ JOHN M
IPC: C07D277/22
Filed: 2020-10-28
Abstract: Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for vascular disorders that can include, for example, retinopathies, ocular edema, and ocular neovascularization.
Patent WO-2021091775-A1 (WO)
Inventor: MUTHUKRISHNAN ARVIND
IPC: G06F16/954
Filed: 2020-10-30
Abstract: Techniques for casting electronic content, including identifying, at a first time, a first action by a user of a presenter device affecting rendering of a content item casted to a target device; determining that the presenter device is in a first casting mode at the first time; based on the presenter device being in the first casting mode at the first time, changing a rendering of the content item by the target device by causing the first action to be reported in real-time to the target device; identifying, at a second time, a second action by the user that affects a rendering of the content item; determining that the presenter device is in a second casting mode at the second time; and determining that the second action will not be reported to the target device based on the presenter device being in the second casting mode at the second time.